We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Latest Industry Insights

Industry Insight

NanoDrop 20 Years On

In this interview, Patrick Brown tells us more about the evolution of NanoDrop over the past 20 years, highlights some of the most important improvements during this time and explores what the future may hold for the technology.
Industry Insight

DMT: A Trip To Get Away From Depression?

The revival of psychedelic medicine is well underway. We spoke with Small Pharma CEO Peter Rands to discuss the unique features of the psychedelic DMT and updates from the company’s latest trials.
Industry Insight

A Path to Net Zero

Agilent recently announced its commitment to achieve net-zero greenhouse gas emissions no later than 2050. We spoke to them to learn how you go about making a global company with 16,300 employees a net-zero business.
Industry Insight

An Interview With Life Chemicals

To learn more about Life Chemicals and the services it provides, Technology Networks spoke with Olga Balabon. In this interview, Olga also highlights how the company supports researchers when searching for appropriate product candidates.
Industry Insight

Innovations and Key Themes for ASMS 2021

While many of us are still attending events remotely, ASMS 2021 has been in full swing this year with in-person talks and events. To give you a taste of the topics proving popular this year, Technology Networks has produced a round up to highlight a selection of key themes and innovations.
Industry Insight

Building a Stronger Clinical Trials Industry Post-Pandemic: Modal-Guided Design

The focus on COVID-19 has caused many trials to be delayed, canceled or scaled back – meaning that the development of new medicines for patients in other areas has been slowed. At the same time, it has exposed pre-existing flaws in the industry. To recover from the pandemic, the industry must now address these underlying issues.
Industry Insight

Can Psilocybin Help Smokers Quit? This Clinical Trial Aims to Find Out

Psilocybin – the primary active ingredient in magic mushrooms – is to be studied in a new clinical trial that will test whether the psychedelic compound can help people quit smoking.
Industry Insight

Building the World’s First University Cloud Lab

To learn more about the CMU Cloud Lab, the motivation behind the project and the benefits it will bring, Technology Networks spoke to Rebecca Doerge, PhD, dean, Mellon College of Science, Carnegie Mellon University, and Toby Blackburn, head of business development and research, Emerald Cloud Lab.
Industry Insight

Large-Scale Bioproduction of Adherent Cells To Support Advanced Therapy Workflows

In recent years, a number of new cell and gene therapies have been developed to treat a variety of indications, including cancer and inherited retinal dystrophies. While these therapies have proven to be beneficial to patients, their scalability and manufacturability are two enduring challenges. Technology Networks spoke to Tara St.Amand, PhD, MBA, director of business technology, bioprocess at Corning to learn more about the key challenges faced when scaling up the manufacturing of cell products.
Industry Insight

Brooks Automation To Unify Services Under Azenta Life Sciences

Technology Networks spoke to Linda De Jesus, senior vice president and chief commercial officer at Azenta Life Sciences to find out more about the announcement and how this will help drive innovation with greater speed and accuracy.
Advertisement